AR-T immunotherapy, in which a body’s own T cells are reengineered to attack a patient’s tumor, has picked up steam in recent years. But T cells aren’t the only immune cells that scientists are tinkering with.

A team of researchers from the University of Central Florida has found that “natural killer cells” in the body may also play a compelling role in attacking cancer. It may be possible to enhance that response by taking immune cells from a cancer patient’s close blood relatives and infusing those into the patient to attack their tumors. Unlike CAR-T therapy, which so far is restricted to use in blood cancers, there’s hope that these NK cells could be used to treat solid tumors as well.

This is a STAT Plus article and you can unlock it by subscribing to STAT Plus today. It's easy! Your first 30 days are free and if you don't enjoy your subscription you can cancel any time.
Already a subscriber? Log in here.

Leave a Comment

Please enter your name.
Please enter a comment.

Sign up for our Morning Rounds newsletter

Your daily dose of what’s new in health and medicine.